Assessment of Denosumab in Korean Postmenopausal Women with Osteoporosis: Randomized, Double-Blind, Placebo-Controlled Trial with Open-Label Extension

The efficacy and safety of denosumab was compared with placebo in Korean postmenopausal women with osteoporosis in this phase III study. Women aged 60 to 90 years with a T-score of

Saved in:
Bibliographic Details
Published in:Yonsei medical journal 2016, 57(4), , pp.905-914
Main Authors: Koh, Jung Min, Chung, Dong Jin, Chung, Yoon Sok, Kang, Moo Il, Kim, In Ju, Min, Yong Ki, Oh, Han Jin, Park, Il Hyung, Lee, Yil Seob, Kravitz, Barbara, Waterhouse, Brian, Nino, Antonio, Fitzpatrick, Lorraine A
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Asian People
Bone Density
Bone Density Conservation Agents - therapeutic use
Denosumab - therapeutic use
Double-Blind Method
Female
Femur
Femur Neck
Humans
Lumbar Vertebrae
Middle Aged
Original
Osteoporosis, Postmenopausal - drug therapy
Osteoporosis, Postmenopausal - ethnology
Postmenopause
Republic of Korea
의학일반
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The efficacy and safety of denosumab was compared with placebo in Korean postmenopausal women with osteoporosis in this phase III study. Women aged 60 to 90 years with a T-score of
ISSN:0513-5796
1976-2437
DOI:10.3349/ymj.2016.57.4.905